Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Common Stock Subscribed But Not Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balances at December 31, 2020 at Dec. 31, 2019	$ 228,408	$ 1,168,074	$ 112,245,730	$ (106,760,527)	$ (553,465)	$ 6,328,220
Shares outstanding, beginning balance at Dec. 31, 2019	228,408,024	3,236,857
Issuance of subscribed shares	$ 3,237	$ (1,168,074)	1,164,837
Shares, Outstanding, Beginning Balance	3,236,857	(3,236,857)
Stock grants		$ 5,365				5,365
Shares outstanding, beginning balance		30,307
Shares, Outstanding, Beginning Balance
Amortization of option grants			317,355			317,355
Discount on debentures payable			28,021			28,021
Beneficial conversion feature on debentures payable			379,183			379,183
Conversion of debentures payable	$ 8,584		1,796,073			1,804,657
Shares, Outstanding, Beginning Balance	8,584,276
Conversion of common stock to preferred stock	$ (4,908)		(14,720,092)			(14,725,000)
Conversion of common stock to preferred stock, shares	(4,908,333)
Shares, Outstanding, Beginning Balance
Shares, Outstanding, Beginning Balance
Distributions					(100,905)	(100,905)
Net income (loss)				(2,421,444)	83,728	(2,337,716)
Balances at March 31, 2021 at Mar. 31, 2020	$ 235,321	$ 5,365	101,211,107	(109,181,971)	(570,642)	(8,300,820)
Shares outstanding, beginning balance at Mar. 31, 2020	235,320,824	30,307
Balances at December 31, 2020 at Dec. 31, 2019	$ 228,408	$ 1,168,074	112,245,730	(106,760,527)	(553,465)	6,328,220
Shares outstanding, beginning balance at Dec. 31, 2019	228,408,024	3,236,857
Balances at March 31, 2021 at Dec. 31, 2020	$ 314,419	$ 5,365	112,974,329	(104,616,538)	(577,139)	8,100,436
Shares outstanding, beginning balance at Dec. 31, 2020	314,418,812	11,413
Issuance of subscribed shares	$ 11	$ (5,365)	5,354
Shares, Outstanding, Beginning Balance	11,413
Stock grants		$ 5,365				5,365
Shares outstanding, beginning balance		6,877
Exercise of warrants	$ 50		7,450			7,500
Shares, Outstanding, Beginning Balance	50,000
Amortization of option grants			294,598			294,598
Issuance of stand-alone warrants			55,786			55,786
Conversion of debentures payable	$ 4,611		1,351,841			1,356,452
Shares, Outstanding, Beginning Balance	4,610,645
Conversion of promissory notes	$ 3,366		1,006,426			1,009,792
Shares, Outstanding, Beginning Balance	3,365,972
Common stock issued to settle obligations	$ 43		31,243			31,286
Shares, Outstanding, Beginning Balance	42,857
Equity issuance costs			(386,983)			(386,983)
Distributions					(82,558)	(82,558)
Net income (loss)				4,219,903	90,123	4,310,026
Balances at March 31, 2021 at Mar. 31, 2021	$ 322,500	$ 5,365	$ 115,340,044	$ (100,396,635)	$ (569,574)	$ 14,701,700
Shares outstanding, beginning balance at Mar. 31, 2021	322,499,699	6,877
Shares outstanding, beginning balance		(11,413)